<PAGE> 1
Prospectus Supplement No. 8 Filed pursuant to Rule 424(b)(3)
to Prospectus dated March 6, 2000 Registration No. 333-31354
ALKERMES, INC.
$250,000,000 3 3/4% CONVERTIBLE SUBORDINATED NOTES DUE 2007
1,845,018 SHARES OF COMMON STOCK
This prospectus supplement supplements the information contained in the
prospectus of Alkermes, Inc. dated March 6, 2000, as supplemented by Prospectus
Supplement No. 1 dated March 10, 2000, Prospectus Supplement No. 2 dated March
17, 2000, Prospectus Supplement No. 3 dated March 24, 2000, Prospectus
Supplement No. 4 dated April 5, 2000, Prospectus Supplement No. 5 dated April
13, 2000, Prospectus Supplement No. 6 dated April 21, 2000 and Prospectus
Supplement No. 7 dated May 4, 2000, relating to the potential resale from time
to time of the 3 3/4% Convertible Subordinated Notes due 2007 of Alkermes and
the resale of shares of common stock of Alkermes issuable upon conversion of the
notes. This prospectus supplement is not complete without, and may not be
delivered or utilized except in connection with, the prospectus, including any
amendments or supplements thereto.
The following table supplements the information set forth in the prospectus
under the caption "Selling Securityholders" with respect to the selling
securityholders and the respective principal amount of notes which are
beneficially owned and may be sold by each selling securityholder, and the
number of shares of common stock that may be sold by the selling securityholders
pursuant to this prospectus, as amended or supplemented:
<TABLE>
<CAPTION>
Number of Shares of Common
Stock Issued Upon Conversion
Principal Amount of Notes of the Notes that May be
Beneficially Owned and Offered(2)
Name of Selling Securityholder(1) Offered
<S> <C> <C>
Credit Suisse First Boston Corporation $1,375,000 10,147
Donaldson, Lufkin & Jenrette Securities Corp.(6) 4,540,000 33,505
</TABLE>
(1) The information set forth herein is as of May 30, 2000 and will be updated
as required.
(2) Assumes conversion of the full principal amount of the notes held by such
holder at the initial conversion price of $135.50 per share of common
stock.
(6) The amount listed includes an additional $40,000 principal amount of the
notes beneficially owned by the holder as of May 10, 2000.
THE DATE OF THIS PROSPECTUS SUPPLEMENT IS MAY 30, 2000
